Page 18 - Mesenchymal Stem cells, Exosomes and vitamins in the fight aginst COVID

Expanded Umbilical Cord Mesenchymal Stem Cells as a Strategy In Managing COVID-19 Illness

105. Frew L, Stock SJ. Antimicrobial peptides 113. Weiss ML, Trover DL. Stem cells in the vector of infection for COVID-19.
and pregnancy. Reproduction 2011; umbilical cord. Stem Cell Rev 2006; Tablet, March 13, 2020. Accessed date
141:725-735. 2:155.162. 3/20/2020.
106. Zanetti M. Cathelicidins, multifunctional 114. Nagamura-Inoue T, He H. Umbilical www.tabletmag.com/jewish-news-
peptides of the innate immunity. J cord-derived mesenchymal stem cells: and-politics/middle-east/300948/iran-
Leukoc Biol 2004; 75:39-48. Their advantages and potential clinical coronavirus-covid-19
107. Bals R, Weiner DJ, Moscioni AD, utility. World J Stem Cells 2014; 6:195- 121. Yamey G. What the U.S. needs to do
Meegalla RL, Wilson JM. Augmentation 202. today to follow South Korea’s model for
of innate host defense by expression of a 115. Tipnis S, Viswanathan C, Majumdar fighting coronavirus. Time, March 17,
cathelicidin antimicrobial peptide. Infect AS. Immunosuppressive properties 2020. Accessed date 3/20/2020
Immun 1999; 67:6084-6089. of human umbilical cord-derived https://time.com/5804899/u-s-
108. Schneider JJ, Unholzer A, Schaller M, mesenchymal stem cells: role of B7-H1 coronavirus-needs-follow-s-korea/ .
Schäfer-Korting M, Korting HC. Human and IDO. Immunol Cell Biol 2010; 88:795- 122. Thacker T, Sharma N. COVID-19 in
defensins. J Mol Med (Berl) 2005; 83:587- 806. India: Cautious government involves
595. 116. Bauer G, Elsallab M, Abou-El-Enein private sector in treatment patients.
109. Krasnodembskaya A, Song Y, Fang X, M. Concise Review: A comprehensive The Economic Times, March 18, 2020.
et al. Antibacterial effect of human analysis of reported adverse events in Accessed date 3/20/2020.
mesenchymal stem cells is mediated in patients receiving unproven stem cell- https://economictimes.indiatimes.com/
part from secretion of the antimicrobial based interventions. Stem Cells Transl industry/healthcare/biotech/healthcare/
peptide LL-37. Stem Cells 2010; 28:2229- Med 2018; 7:676-685. cautious-govt-involves-private-sector/
2238. 117. Rosenbaum L. Facing Covid-19 in Italy articleshow/74681205.cms?from=mdr
110. Sutton MT, Fletcher D, Ghosh SK, - Ethics, Logistics, and Therapeutics on 123. Gostin LO, Hodge JG, Wiley LF.
et al. Antimicrobial properties of the Epidemic’s Front Line. N Engl J Med Presidential powers and response to
mesenchymal stem cells: therapeutic 2020 Mar 18. [Epub ahead of print] COVID-19. JAMA 2020 Mar 18. [Epub
potential for cystic fibrosis infection and 118. French Gouvernement. Coming to ahead of print].
treatment. Stem Cells Int 2016; 2016:12. France? Is it safe to come to France? 124. James S. Brady Press Briefing Room.
111. Hernigou P, Trousselier M, Roubineau F, Coronavirus COVID-19. March 18, 2020. Remarks by President Trump, Vice
et al. Stem cell therapy for the treatment Accessed date 3/20/2020 President Pence, and Members of
of hip osteonecrosis: A 30-year review of www.gouvernement.fr/en/coronavirus- the Coronavirus Task Force in Press
progress. Clin Orthop Surg 2016; 8:1-8. covid-19. Briefing. March 14, 2020. Accessed date
112. Arutyunyan I, Elchaninov A, Makarov 119. French Gouvernement. Coronavirus 3/15/2020.
A, Fatkhudinov T. Umbilical Cord as COVID-19. March 18, 2020. Accessed www.whitehouse.gov/briefings-
Prospective Source for Mesenchymal date 3/20/2020. statements/remarks-president-trump-
Stem Cell-Based Therapy. Stem Cells Int www.gouvernement.fr/en/coronavirus- vice-president-pence-members-
2016; 2016:6901286. covid-19 coronavirus-task-force-press-briefing/
120. Blum N. How Iran became a global

www.painphysicianjournal.com E83